Bellevue, WA, United States of America

Manjari Lal

USPTO Granted Patents = 8 

Average Co-Inventor Count = 1.7

ph-index = 4

Forward Citations = 68(Granted Patents)


Location History:

  • Bellevue, WA (US) (2004 - 2007)
  • Redmond, WA (US) (2006 - 2007)

Company Filing History:


Years Active: 2004-2007

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Manjari Lal

Introduction

Manjari Lal is a prominent inventor based in Bellevue, WA (US), known for his significant contributions to the field of pharmaceuticals. With a total of 8 patents to his name, he has made remarkable advancements in the development of platinum compounds and their applications in treating cellular proliferative diseases.

Latest Patents

Among his latest patents, Manjari has developed multinuclear platinum compounds, which include compositions that feature these platinum compounds. He has also created methods for making these compounds and for treating cellular proliferative diseases through their administration. Additionally, he has patented various platinum compounds, including pharmaceutically acceptable salts and prodrugs. His work emphasizes the use of these compounds, either alone or in combination with other therapeutic agents, for the prophylaxis or treatment of proliferative diseases.

Career Highlights

Manjari Lal is currently associated with Sonus Pharmaceuticals, Inc., where he continues to innovate and contribute to the pharmaceutical industry. His expertise in platinum compounds has positioned him as a key figure in the development of new therapeutic strategies.

Collaborations

Throughout his career, Manjari has collaborated with notable colleagues, including Yuehua Zhang and Nagesh Palepu. These collaborations have further enhanced his research and development efforts in the field.

Conclusion

Manjari Lal's innovative work in the realm of platinum compounds and their therapeutic applications showcases his dedication to advancing medical science. His contributions are paving the way for new treatments in the fight against proliferative diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…